Clin2
NCT06292598Possibly a fitRecruiting

Gut bacteria and sleep disorder study

Narcolepsy Type 1Bacterial Translocation

Treatments studied

Part of Brain & nervous system, Digestive system, Infections clinical trials.

This study compares gut bacteria and substances from the gut in people with type 1 narcolepsy versus those without. It aims to understand how gut health might be linked to this sleep disorder.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
10 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with type 1 narcolepsy.
  • You are not currently taking narcolepsy medication at the time of first joining the study.
  • You speak and understand French.
  • You have health insurance.
  • You have not taken antibiotics in the last 3 months, and do not have a chronic digestive condition or have had weight-loss surgery in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06336057Recruiting
Mentalizing in adults with narcolepsy type 1

This study looks at how people with type 1 narcolepsy understand their own and others' thoughts and feelings (called mentalizing). It compares them to people with treated sleep apnea to see if there are differences.

Toulouse
NCT06484348Recruiting
How food affects sleepiness in narcolepsy and hypersomnia

This study explores how what you eat affects your sleepiness and nighttime sleep quality. Researchers want to learn more about these links in people with narcolepsy type 1 or idiopathic hypersomnia.

Clermont-Ferrand
NCT07299097Recruiting
Narcolepsy type 1 and type 2 study in Spain

This study looks at people with narcolepsy type 1 or type 2 in Spain to learn more about these conditions. If you or your child has a confirmed diagnosis, you may be able to take part.

Castellon, Castellon
NCT07540897Recruiting· Phase 3
Testing ALKS 2680 for narcolepsy type 1

This study tests whether a new medication called ALKS 2680 can help people with narcolepsy type 1 stay more awake and alert during the day. Narcolepsy type 1 is a neurological condition where people fall asleep unexpectedly and may experience sudden muscle weakness.

Miami, Florida
NCT07455383Recruiting· Phase 3
Testing ALKS 2680 for adults with narcolepsy type 1

This study tests a new medication, ALKS 2680, to see if it helps reduce daytime sleepiness and other symptoms in adults with narcolepsy type 1. It may offer a new treatment option for people with this condition.

Cullman, Alabama
NCT07766343Not yet recruiting
Sleep disorders in children and teenagers

This study looks at how common sleep disorders affect children and teens. It may help us understand and treat conditions like poor sleep, tiredness during the day, and other sleep issues.

Montpellier, Hérault

Hear when a new Narcolepsy Type 1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.